Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Foshan
Clinical trial register · China

Clinical Trials in Foshan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 23 Changchun 18 Guangzhou 18 Hangzhou 18 Chengdu 15
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University14 AstraZeneca12 Janssen Research & Development, LLC6 Eli Lilly and Company5 Guangdong Association of Clinical Trials5 Novartis Pharmaceuticals4 Guangdong Provincial People's Hospital4 Boehringer Ingelheim3 Zhujiang Hospital3 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2 Pfizer2 First People's Hospital of Foshan2 Chinese Academy of Medical Sciences, Fuwai Hospital2 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.2 Bristol-Myers Squibb2 Zhongshan Ophthalmic Center, Sun Yat-sen University2 Sanofi2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2 Ausper Biopharma Co., Ltd.2 Nanfang Hospital, Southern Medical University2 Biotheus Inc.2 Peking Union Medical College Hospital2 Merck Sharp & Dohme LLC2 Simcere Pharmaceutical Co., Ltd1 ScinnoHub Pharmaceutical Co., Ltd.1 MediLink Therapeutics (Suzhou) Co., Ltd.1 Beijing Friendship Hospital1 Shandong Provincial Hospital1 Incyte Corporation1 Beijing InnoCare Pharma Tech Co., Ltd.1 Shenzhen Ionova Life Sciences Co., Ltd.1 Amgen1 Summit Therapeutics1 Daiichi Sankyo1 TJ Biopharma Co., Ltd.1 Seagen, a wholly owned subsidiary of Pfizer1 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 Laekna Limited1 a2 Milk Company Ltd.1 First Affiliated Hospital of Zhejiang University1 Capital Medical University1 Lepu Medical Technology (Beijing) Co., Ltd.1 Taizhou Hanzhong biomedical co. LTD1 Hai-Qiang Mai,MD,PhD1 ArriVent BioPharma, Inc.1 Alpha Biopharma (Jiangsu) Co., Ltd.1 Heilongjiang Feihe Dairy Co. Ltd.1 Sinotau Pharmaceutical Group1 First Affiliated Hospital of Shantou University Medical College1 NewAmsterdam Pharma1 Zai Lab (Shanghai) Co., Ltd.1 Shanghai Mental Health Center1 Sixth Affiliated Hospital, Sun Yat-sen University1 Genor Biopharma Co., Ltd.1 CStone Pharmaceuticals1 Candid Therapeutics1 Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences1 Beijing Continent Pharmaceutical Co, Ltd.1 Shanghai Gynecologic Oncology Group1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Shenzhen Genocury Biotech Co., Ltd.1 ChromX Health1 South China Normal University1 Excyte Biopharma Ltd1 Takeda1 Yongquan Shi1 Shanghai Jiao Tong University School of Medicine1 Novo Nordisk A/S1 Hoffmann-La Roche1 RemeGen Co., Ltd.1 Betta Pharmaceuticals Co., Ltd.1 Hangzhou Endonom Medtech Co., Ltd.1 Sun Yat-Sen University Cancer Center1 Guangzhou Women and Children's Medical Center1 BeOne Medicines1 Ascentage Pharma Group Inc.1 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University1 Clear sponsor filter
Target enrolment
to

Trials with a site in Foshan

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
NCT06210776HER2-positive Breast Cancer, HER2-low Breast Cancer, Breast Cancer, Advanced Cancer
Daiichi Sankyo
Observational
800
Beijing, Chengdu, Dalian, Foshan, Fuzhou, Guangzhou, Haikou, Hangzhou
2024-01-15
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/foshan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Foshan that also match the filters currently applied.

How many clinical trials are recruiting in Foshan?

1 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Foshan), 1 studies
PhaseStudiesRecruitingShare
Observational11100%

Most active sponsors

Lead sponsors with the most studies (Foshan)
Lead sponsorStudiesRecruiting
Daiichi Sankyo11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.